Mostrar el registro sencillo del ítem
Dengue and COVID‐19, overlapping epidemics? An analysis from Colombia
dc.contributor.author | Cardona‐Ospina, Jaime A. | |
dc.contributor.other | Arteaga‐Livias, Kovy | |
dc.contributor.other | Villamil‐Gómez, Wilmer E. | |
dc.contributor.other | Pérez‐Día, Carlos E. | |
dc.contributor.other | Bonilla‐Aldana, D. Katterine | |
dc.contributor.other | Mondragon‐Cardona, Álvaro | |
dc.contributor.other | Solarte‐Portilla, Marco | |
dc.contributor.other | Martinez, Ernesto | |
dc.contributor.other | Millan‐Oñate, Jose | |
dc.contributor.other | López‐Medina, Eduardo | |
dc.contributor.other | López, Pio | |
dc.contributor.other | Navarro, Juan‐Carlos | |
dc.contributor.other | Perez‐Garcia, Luis | |
dc.contributor.other | Mogollon‐Rodriguez, Euler | |
dc.contributor.other | Rodríguez‐Morales, Alfonso J. | |
dc.contributor.other | Paniz‐Mondolfi, Alberto | |
dc.date.accessioned | 2022-11-15T20:50:50Z | |
dc.date.available | 2022-11-15T20:50:50Z | |
dc.date.issued | 2020-06-16 | |
dc.date.submitted | 2020-05-23 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12834/896 | |
dc.description.abstract | Coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has rapidly spread throughout Latin America, a region swept by multiple previous and ongoing epidemics. There are significant concerns that the arrival of COVID‐19 is currently overlapping with other viruses, particularly dengue, in various endo‐epidemic regions across South America. In this report, we analyzed trends for both viral infections in Colombia during the first 20 epidemiological weeks (EWs) of 2020. From 1st January to 16th May 2020 (EWs, 1‐ 20), a total of 52 679 cases of dengue and 14 943 cases of COVID‐19 have been confirmed in Colombia. As both conditions may potentially lead to fatal outcomes, especially in patients with chronic co‐morbidities, overlapping infections, and co‐ occurrence may increase the number of patients requiring intensive care and mechanical ventilation. In regions, such as Valle del Cauca, intensified preparation for such scenarios should be pondered, and further studies should be performed to address this critical issue in a timely matter | spa |
dc.format.mimetype | application/pdf | spa |
dc.language.iso | eng | spa |
dc.source | Journal Of Medical Virology | spa |
dc.title | Dengue and COVID‐19, overlapping epidemics? An analysis from Colombia | spa |
dcterms.bibliographicCitation | 1. Rodriguez‐Moralesodriguez‐Morales AJ, Gallego V, Escalera‐ Antezana JP, et al. COVID‐19 in Latin America: the implications of the first confirmed case in Brazil. Travel Med Infect Dis. 2020:101613. | spa |
dcterms.bibliographicCitation | 2. Sanchez‐Duque JA, Arce‐Villalobos LR, Rodriguez‐Morales AJ. Coronavirus disease 2019 (COVID‐19) in Latin America: role of primary care in preparedness and response. Aten Primaria. 2020;52(6):369‐372. | spa |
dcterms.bibliographicCitation | 3. Rodriguez‐Morales AJ, Suarez JA, Risquez A, Delgado‐Noguera L, Paniz‐ Mondolfi A. The current syndemic in Venezuela: measles, malaria, and more coinfections coupled with a breakdown of social and healthcare infrastructure. Quo vadis? Travel Med Infect Dis. 2019;27:5‐8. | spa |
dcterms.bibliographicCitation | 4. PAHO. Epidemiological Update Dengue—7th February 2020. 2020. https://www.paho.org/hq/index.php?option=com_docman&view= download&category_slug=dengue-2217&alias=51690-7-february2020-dengue-epidemiological-update-1&Itemid=270&lang=en | spa |
dcterms.bibliographicCitation | 5. Yanan G, Lee CK, Lam LTM, et al. Covert COVID‐19 and false‐positive dengue serology in Singapore. Lancet Infect Dis. 2020;20(5):536 | spa |
dcterms.bibliographicCitation | 6. Zambrano LI, Rodriguez E, Espinoza‐Salvado IA, Rodriguez‐Morales AJ. Dengue in Honduras and the Americas: the epidemics are back! Travel Med Infect Dis. 2019;31:101456 | spa |
dcterms.bibliographicCitation | 7. Navarro JC, Arrivillaga‐Henriquez J, Salazar‐Loor J, Rodriguez‐ Morales AJ. COVID‐19 and dengue, co‐epidemics in Ecuador and other countries in Latin America: pushing strained health care systems over the edge. Travel Med Infect Dis. 2020:101656. | spa |
dcterms.bibliographicCitation | 8. Biswaliswal S, Borja‐Tabora C, Martinez Vargas L, et al. Efficacy of a tetravalent dengue vaccine in healthy children aged 4‐16 years: a randomized, placebo‐controlled, phase 3 trial. Lancet. 2020; 395(10234):1423‐1433. | spa |
dcterms.bibliographicCitation | 9. Biswalswal S, Reynales H, Saez‐Llorens X, et al. Efficacy of a tetravalent dengue vaccine in healthy children and adolescents. N Engl J Med. 2019;381(21):2009‐2019. | spa |
dcterms.bibliographicCitation | 10. Haqqi A, Awan UA, Ali M, Saqib MAN, Ahmed H, Afzal MS. COVID‐19 and dengue virus co‐epidemics in Pakistan: a dangerous combination for overburdened healthcare system. J Med Virol. 2020. https://doi. org/10.1002/jmv.26144 | spa |
dcterms.bibliographicCitation | 11. Quintero‐Herrera LL, Ramírez‐Jaramillo V, Bernal‐Gutiérrez S, et al. Potential impact of climatic variability on the epidemiology of dengue in Risaralda, Colombia, 2010‐2011. J Infect Public Health. 2015;8(3):291‐297. | spa |
dcterms.bibliographicCitation | 12. Pinky L, Dobrovolny HM. Coinfections of the respiratory tract: viral competition for resources. PLoS One. 2016;11(5):e0155589. | spa |
dcterms.bibliographicCitation | 13. Guzik TJ, Mohiddin SA, Dimarco A, et al. COVID‐19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res. 2020. https://doi.org/10.1093/cvr/ cvaa106 | spa |
dcterms.bibliographicCitation | 14. Wilder‐Smith A, Ooi EE, Horstick O, Wills B. Dengue. Lancet. 2019; 393(10169):350‐363. | spa |
dcterms.bibliographicCitation | 15. Hernandez‐Fonseca JP, Duran A, Valero N, Mosquera J. Losartan and enalapril decrease viral absorption and interleukin 1 beta production by macrophages in an experimental dengue virus infection. Arch Virol. 2015;160(11):2861‐2865 | spa |
dcterms.bibliographicCitation | 16. Wilder‐Smith A, Chiew CJ, Lee VJ. Can we contain the COVID‐19 outbreak with the same measures as for SARS? Lancet Infect Dis. 2020; 20(5):e102‐e107. | spa |
dcterms.bibliographicCitation | 17. Azekawa S, Namkoong H, Mitamura K, Kawaoka Y, Saito F. Co‐ infection with SARS‐CoV‐2 and influenza A virus. IDCases. 2020;20: e00775. | spa |
dcterms.bibliographicCitation | 18. Rodriguez JA, Rubio‐Gomez H, Roa AA, Miller N, Eckardt PA. Coinfection with SARS‐COV‐2 and parainfluenza in a young adult patient with pneumonia: case report. IDCases. 2020;20:e00762. | spa |
dcterms.bibliographicCitation | 19. Sánchez‐Duque JA, Orozco‐Hernández JP, Marín‐Medina DS, et al. Are we now observing an increasing number of coinfections between SARS‐CoV‐2 and other respiratory pathogens? J Med Virol. 2020. https://doi.org/10.1002/jmv.26089 | spa |
dcterms.bibliographicCitation | 20. Perez MA, Gordon A, Sanchez F, et al. Severe coinfections of dengue and pandemic influenza A H1N1 viruses. Pediatr Infect Dis J. 2010; 29(11):1052‐1055 | spa |
dcterms.bibliographicCitation | 21. Bokhari SMMA, Mahmood F, Bokhari SMSA. Case report: diagnosis of novel coronavirus disease (COVID‐19) versus tropical diseases in Pakistan. Am J Trop Med Hyg. 2020. https://doi.org/10.4269/ajtmh. 20-0356 | spa |
dcterms.bibliographicCitation | 22. Lorenz C, Azevedo TS, Chiaravalloti‐Neto F. COVID‐19 and dengue fever: a dangerous combination for the health system in Brazil. Travel Med Infect Dis. 2020:101659. | spa |
dcterms.bibliographicCitation | 23. Merad M, Martin JC. Pathological inflammation in patients with COVID‐19: a key role for monocytes and macrophages. Nat Rev Immunol. 2020;20(6):355‐362. | spa |
dcterms.bibliographicCitation | 24. Villamil‐Gomez WE, Gonzalez‐Camargo O, Rodriguez‐Ayubi J, Zapata‐Serpa D, Rodriguez‐Morales AJ. Dengue, chikungunya, and Zika co‐infection in a patient from Colombia. J Infect Public Health. 2016;9(5):684‐686 | spa |
dcterms.bibliographicCitation | 25. Díaz‐Guio DA, Villamil‐Gómez WE, Dajud L, et al. Will the Colombian intensive care units collapse due to the COVID‐19 pandemic? Travel Med Infect Dis. 2020:101746. | spa |
datacite.rights | http://purl.org/coar/access_right/c_abf2 | spa |
oaire.resourcetype | http://purl.org/coar/resource_type/c_6501 | spa |
oaire.version | http://purl.org/coar/version/c_970fb48d4fbd8a85 | spa |
dc.audience | Público general | spa |
dc.identifier.doi | 10.1002/jmv.26194 | |
dc.identifier.instname | Universidad del Atlántico | spa |
dc.identifier.reponame | Repositorio Universidad del Atlántico | spa |
dc.subject.keywords | Colombia, COVID‐19, dengue, Latin America, overlapping, SARS‐CoV‐2, syndemic | spa |
dc.type.driver | info:eu-repo/semantics/article | spa |
dc.type.hasVersion | info:eu-repo/semantics/publishedVersion | spa |
dc.type.spa | Artículo | spa |
dc.publisher.place | Barranquilla | spa |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | spa |
dc.publisher.discipline | Doctorado en Medicina Tropical | spa |
dc.publisher.sede | Sede Norte | spa |